These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 27365760)
41. [Clinical significance of bcl-2 protein expression and classification algorithm in diffuse large B-cell lymphoma]. Li M; Liu CL; Wang XY; Xue XM; Gao ZF Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):813-7. PubMed ID: 23324229 [TBL] [Abstract][Full Text] [Related]
42. [Immunohistochemical classification and prognosis of diffuse large B-cell lymphoma in China]. Chen Y; Xiao L; Zhu X; Lu C; Yu B; Fan D; Yin Y Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):383-8. PubMed ID: 25208988 [TBL] [Abstract][Full Text] [Related]
43. Prognostic Significance of Bcl-2 Expression in Non-germinal Center B-cell-Like Diffuse Large B-cell Lymphoma. Alford D; Petković I Cureus; 2024 Jun; 16(6):e62031. PubMed ID: 38989351 [TBL] [Abstract][Full Text] [Related]
44. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation. Costa LJ; Feldman AL; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Ansell SM Br J Haematol; 2008 Jul; 142(3):404-12. PubMed ID: 18492096 [TBL] [Abstract][Full Text] [Related]
45. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China]. Chen Y; Chen H; Fu K; Zhu XZ; Irons R Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):313-8. PubMed ID: 20654154 [TBL] [Abstract][Full Text] [Related]
46. Gastric and intestinal diffuse large B-cell lymphomas are clinically and immunophenotypically different. An immunohistochemical and clinical study. Connor J; Ashton-Key M Histopathology; 2007 Nov; 51(5):697-703. PubMed ID: 17927592 [TBL] [Abstract][Full Text] [Related]
47. Prognostic Significance of High Ki-67 Index and Histogenetic Subclassification in Primary Central Nervous System Lymphoma. Cho U; Oh WJ; Hong YK; Lee YS Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):254-262. PubMed ID: 27490760 [TBL] [Abstract][Full Text] [Related]
48. [Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma]. Han YS; Xue YQ; Yang HY; Zhang J; Pan JL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):143-7. PubMed ID: 23568722 [TBL] [Abstract][Full Text] [Related]
49. Differences in germinal centre and non-germinal center phenotype in gastric and intestinal diffuse large B-cell lymphomas. Mitchell KA; Finn WG; Owens SR Leuk Lymphoma; 2008 Sep; 49(9):1717-23. PubMed ID: 18798105 [TBL] [Abstract][Full Text] [Related]
50. Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation. Song Y; Cao Z; Li L; Zhang HT; Zhang X Chin J Cancer; 2010 Sep; 29(9):781-6. PubMed ID: 20800019 [TBL] [Abstract][Full Text] [Related]
51. [PROGNOSTIC ROLE OF NF-κB EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUPS]. Škunca Z; Planinc-Peraica A Acta Med Croatica; 2015 Mar; 69(1):25-32. PubMed ID: 26606782 [TBL] [Abstract][Full Text] [Related]
52. Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful. Martin-Arruti M; Vaquero M; Díaz de Otazu R; Zabalza I; Ballesteros J; Roncador G; García-Orad A Histopathology; 2012 Apr; 60(5):785-92. PubMed ID: 22321048 [TBL] [Abstract][Full Text] [Related]
53. [Gene expression profiling of diffuse large B-cell lymphoma in China]. Liu YH; Li L; Liu G; Zhuang HG; Luo DL; Luo XL; Xu J Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):79-83. PubMed ID: 17493379 [TBL] [Abstract][Full Text] [Related]
54. Immunological subtypes analysis of Uygur diffuse large B-cell lymphoma in Xinjiang and their prognostic significance. Jia CD; Liang LP; Yang LL; Yue N; Zhao F; Bai JP J Cancer Res Ther; 2015; 11(4):852-6. PubMed ID: 26881530 [TBL] [Abstract][Full Text] [Related]
55. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases]. Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996 [TBL] [Abstract][Full Text] [Related]
56. Primary central nervous system diffuse large B-cell lymphoma in the immunocompetent: Immunophenotypic subtypes and Epstein-Barr virus association. Mahadevan A; Rao CR; Shanmugham M; Shankar SK J Neurosci Rural Pract; 2015 Jan; 6(1):8-14. PubMed ID: 25552844 [TBL] [Abstract][Full Text] [Related]
57. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1. Hoeller S; Schneider A; Haralambieva E; Dirnhofer S; Tzankov A Histopathology; 2010 Jul; 57(1):73-80. PubMed ID: 20579129 [TBL] [Abstract][Full Text] [Related]
58. Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation. Hashmi AA; Iftikhar SN; Nargus G; Ahmed O; Asghar IA; Shirazi UA; Afzal A; Irfan M; Ali J Cureus; 2021 Feb; 13(2):e13155. PubMed ID: 33692924 [TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical subtypes of diffuse large B-cell lymphoma in the head and neck region. Li JM; Hou J; Li L; Wang Y Genet Mol Res; 2015 Apr; 14(2):3889-96. PubMed ID: 25966160 [TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases. Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S J Clin Pathol; 2003 Oct; 56(10):747-52. PubMed ID: 14514777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]